| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Co-ceo Cib | Co-ceo Ccb +1 more
2 companies
Jennifer Piepszak is Chief Operating Officer at VYLD and has filed Form 4s across 2 companies. Jennifer Piepszak's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $32.6M at current prices.
Historically, Jennifer Piepszak's trades have earned a below-average insider score of 46/100 across 15 rated trades. Over a 12-month horizon, 8.3% of those trades were profitable, with an average 12-month return of -25.2%.
The biggest single holding is JPM (~$29.8M) as Chief Operating Officer. The JPM filings lean toward selling, a net 97,549 shares.
Jennifer Piepszak has 32 Form 4 filings on record from October 2019 to June 2026, across 2 companies: Chief Operating Officer at JPMorgan Chase & (JPM), 2019–2026; Chief Operating Officer at Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD), 2026.
The 59 reported transactions were 21 option exercises, 19 open-market sales, 14 tax withholdings and 5 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 19 sales worth about $21.6M.
The largest open-market sale was 9,136 shares of VYLD at an average $306.56 on April 15, 2026, about $2.8M.
All 12 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | JPM Jpmorgan Chase & Co. | Chief Operating Officer | Sell10b5-1 | 4,919 | $309.42 | $1,522,037.47 | -5.5% | +14.0% | - | |
| Apr 15, 2026 | VYLD Inverse Vix Short-Term Futures Etns Due March 22, 2045 | Chief Operating Officer | Sell10b5-1 | 9,136 | $306.56 | $2,800,712.97 | -9.2% | +7.0% | - | |
| Jan 16, 2026 | JPM Jpmorgan Chase & Co | Chief Operating Officer | Sell10b5-1 | 8,571 | $312.79 | $2,680,887.95 | -10.8% | -0.8% | - | |
| Jun 5, 2025 | JPM Jpmorgan Chase & Co | Chief Operating Officer | Sell10b5-1 | 6,128 | $262.47 | $1,608,424.13 | -8.9% | +14.3% | +19.2% | |
| May 6, 2025 | JPM Jpmorgan Chase & Co | Chief Operating Officer | Sell10b5-1 | 6,129 | $250.76 | $1,536,930.72 | -8.2% | +18.1% | +26.3% | |
| Mar 24, 2025 | JPM Jpmorgan Chase & Co | Chief Operating Officer | Sell10b5-1 | 4,272 | $247.03 | $1,055,314.30 | -7.8% | +12.2% | +17.9% | |
| Feb 20, 2025 | JPM Jpmorgan Chase & Co | Chief Operating Officer | Sell10b5-1 | 4,273 | $269.85 | $1,153,078.02 | -7.3% | -2.2% | +16.5% | |
| May 8, 2024 | JPM Jpmorgan Chase & Co | Co-ceo Cib | Sell10b5-1 | 8,831 | $193.66 | $1,710,186.73 | -17.5% | +2.4% | +29.6% | |
| Feb 16, 2024 | JPM Jpmorgan Chase & Co | Co-ceo Cib | Sell10b5-1 | 1,648 | $178.96 | $294,918.50 | -4.8% | +13.1% | +54.5% | |
| Jan 16, 2024 | JPM Jpmorgan Chase & Co | Co-ceo Ccb | Sale+OE10b5-1 | 1,649 | $166.59 | $274,708.72 | -4.6% | +8.9% | +50.2% |